Docoh
Loading...

TNDM Tandem Diabetes Care

News

Pro users get this 30m faster
SVB Leerink Maintains Market Perform on Tandem Diabetes Care, Raises Price Target to $135
24 Sep 21
News, Price Target, Analyst Ratings
SVB Leerink analyst Danielle Antalffy maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Market Perform and raises the price target from $123 to $135.
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
9 Sep 21
Biotech, Earnings, News, Penny Stocks, Small Cap, FDA
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8)
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
8 Sep 21
Biotech, News, Penny Stocks, Offerings, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7)
72 Biggest Movers From Yesterday
8 Sep 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth.
45 Stocks Moving In Tuesday's Mid-Day Session
7 Sep 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers IronNet, Inc. (NYSE: IRNT) shares jumped 50.4% to $25.06 after jumping over 23% on Friday.
23 Stocks Moving in Tuesday's Pre-Market Session
7 Sep 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers IronNet, Inc. (NYSE: IRNT) rose 89.7% to $31.61 in pre-market trading after jumping over 23% on Friday.
5 Stocks Insiders Are Selling
19 Aug 21
News, Insider Trades, Intraday Update, Markets, Trading Ideas
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.
Raymond James Maintains Outperform on Tandem Diabetes Care, Raises Price Target to $120
5 Aug 21
News, Price Target, Analyst Ratings
Raymond James analyst Jayson Bedford maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Outperform and raises the price target from $115 to $120.
SVB Leerink Maintains Market Perform on Tandem Diabetes Care, Raises Price Target to $123
5 Aug 21
News, Price Target, Analyst Ratings
SVB Leerink analyst Danielle Antalffy maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Market Perform and raises the price target from $102 to $123.
12 Health Care Stocks Moving In Wednesday's After-Market Session
4 Aug 21
Movers
Gainers
Tandem Diabetes Care Sees FY21 Sales $670M-$685M vs $637.16M Est.
4 Aug 21
News, Guidance
2021 Annual Guidance Update For the year ending December 31, 2021, the Company is updating its financial guidance as follows: Sales are estimated to be in the range of $670
Tandem Diabetes Care Q2 EPS $0.06 Beats $(0.08) Estimate, Sales $172.10M Beat $143.63M Estimate
4 Aug 21
Earnings, News
Tandem Diabetes Care (NASDAQ:TNDM) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.08) by 175 percent. This is a 113.33 percent increase over losses of $(0.45) per share
Earnings Scheduled For August 4, 2021
4 Aug 21
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.